secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001641172-25-017590
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve all four proposals at Insight Molecular Diagnostics 2025 annual meeting
--------------------------------------------------------------------------------

- 73.46% quorum achieved; all four director nominees (Riggs, Arno, Last, Silverman) elected.
- Ratified CBIZ CPAs P.C. as independent auditor for FY 2025 with 20,986,994 votes for.
- Non-binding say-on-pay proposal approved with 18,063,639 votes for.
- Amendment to 2018 Equity Incentive Plan approved; shares authorized increased by 1,500,000 to 3,800,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000164117225017590/0001641172-25-017590-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000164117225017590/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017590

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer